Effect of cilostazol on endothelial cell denudation and proliferation in canine vein grafts

Surgery Today

Volumn 31, Issue 10, 2001, Pages 891-894

  Fuxian, Zhang ^a   Nishibe, Toshiya ^b   Yasuda, Keishu ^b   Yingji, Jin ^a   Changming, Zhang ^a   Zuotian, Ma ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Cilostazol; Denudation; Endothelial cell; Proliferation; Vein graft

Indexed keywords

CILOSTAZOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY BYPASS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ILIAC ARTERY; JUGULAR VEIN; NONHUMAN; VEIN GRAFT;

ANIMALS; CELL DIVISION; DOGS; ENDOTHELIUM, VASCULAR; JUGULAR VEINS; TETRAZOLES; VASODILATOR AGENTS;

EID: 0034756027     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950170029     Document Type: Article

References (21)

1. Autogenous vein grafts
2. Structural and functional consequences of bypass grafting with autogenous vein
3. Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. II: 6-[3-(1-cyxlohexyl-5-tetrazolyl)propoxyl]-1,2-dihydro-2-oxoquinoline and related compounds
4. Effect of cilostazol on platelet aggregation and experimental thrombosis
5. Effect of cilostazol, a selective cAMP phosphodiesterase inhibitor on the contraction of vascular smooth muscle
6. Thermographic evaluation of the hemodynamic effect of the anti-thrombotic drug cilostazol in peripheral arterial occlusion
7. Role of hepatocyte growth factor in endothelial regulation: Prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor
8. Effects of cilostazol, an antiplatelet drug, on smooth muscle cell proliferation after endothelial denudation in rats
9. Pharmacologic treatment of intimal hyperplasia after metallic stent placement in the peripheral arteries
10. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts
11. Immediate-early gene expression in human saphenous veins harvested during coronary artery bypass graft operations
12. Histologic fate and endothelial changes of distended and non-distended vein grafts
13. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle
14. Comparison of response to injury in organ cultures of human saphenous vein and internal mammary artery
15. Comparison of the inhibitory effects of cilostazol, acetylsalicylic acid and ticlopidine on platelet functions ex vivo
16. Cilostazol has beneficial effects in treatment of intermittent claudication. Results from a multicenter randomized, prospective, double-blind trial
17. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty
18. A vascular modulator, hepatocyte growth factor, is associated with systolic blood pressure
19. Hepatocyte growth factor (HGF) is a novel member of the endothelial-specific growth factors: Additive stimulatory effect of hepatocyte growth factor with fibroblast growth factor, but not with vascular endothelial growth factor
20. Endothelial preservation in reversed and in situ autogenous vein grafts
21. Comparison of the effects of acetylsalicylic acid, ticlopidine and cilostazol on primary hemostasis using a quantitative bleeding time test apparatus